Overview
Portfolio
More
Oxonian Ventures
Palo Alto, United States
Early‑stage venture fund investing in Oxford alumni‑founded companies, using capital from Oxford alumni and affiliated institutions to support founders and elevate the visibility of Oxonian ventures.
Portfolio
34+
Employees
25+
Founded
2016
AUM
N/A
Investment focus
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Fund details
Funds
Oxonian Ventures Fund III
Sources
Oxonian Ventures
Early‑stage venture fund investing in Oxford alumni‑founded companies, using capital from Oxford alumni and affiliated institutions to support founders and elevate the visibility of Oxonian ventures.
Portfolio
34+
Employees
25+
Founded
2016
AUM
N/A
Funds
Oxonian Ventures Fund III
Stages
No stages listed
Industries
No industries listedGeographic scope
United States
Sources
Showing 24 of 27 matched portfolio companies
AOA Dx is developing GlycoLocate™, a multi-omics platform that utilizes tumor marker gangliosides for early-stage cancer detection, specifically through the AKRIVIS GD™ liquid biopsy test for ovarian cancer. This technology offers high sensitivity and specificity, addressing the critical need for effective early diagnosis in women's health.
Funding: $24.5M
Rough estimate of the amount of funding raised
Funding: $24.5M
Rough estimate of the amount of funding raised
Apero Health provides a modular healthcare software platform that integrates scheduling, patient billing, and revenue cycle management, enabling practices to streamline operations and reduce billing time by up to 80%. The platform enhances financial transparency for patients and practices through real-time eligibility checks and automated workflows, addressing inefficiencies in medical billing and payment processes.
Funding: $150.0K
Rough estimate of the amount of funding raised
Funding: $150.0K
Rough estimate of the amount of funding raised
This company develops proprietary causal genome datasets that map genetic loci to downstream effects on biomarker levels and disease risk. They utilize AI-driven causal modeling to accurately predict drug efficacy and identify optimal indications for novel drug assets. Their platform supports biopharma partners in drug and target discovery, leading to successful licensing and funding outcomes.
Bloom Labs utilizes bio-manufacturing and advanced protein engineering to convert natural waste by-products into high-performance pellets that can be spun into fibers, emulating the properties of cotton, silk, and polyester. This technology addresses the environmental impact of fossil fuel-based synthetic fibers, which contribute to microplastic pollution and are non-biodegradable.
Funding: $2.9M
Rough estimate of the amount of funding raised
Funding: $2.9M
Rough estimate of the amount of funding raised
BluumBio utilizes enzyme-based bioremediation technologies to remove industrial pollutants such as petroleum, pesticides, and plastics from soil, air, and water. By harnessing naturally occurring enzymes from fungi, bacteria, and tropical trees, the company restores ecosystems and promotes biodiversity within 6-12 months of project initiation.
Funding: $125.0K
Rough estimate of the amount of funding raised
Funding: $125.0K
Rough estimate of the amount of funding raised
CNote provides a secure platform for FDIC-insured deposits and fixed income solutions, connecting investors with a vetted network of Minority Depository Institutions and Community Development Financial Institutions (CDFIs). This approach directly channels capital into underserved communities, creating jobs and supporting BIPOC-owned small businesses while promoting economic and racial justice.
Funding: $16.1M
Rough estimate of the amount of funding raised
American Family Insurance Institute for Corporate and Social Impact
American Family Insurance Institute for Corporate and Social Impact
Funding: $16.1M
Rough estimate of the amount of funding raised
This company develops software infrastructure to operate quantum computers across the entire stack. Coda provides a natural language interface that generates and executes quantum programs, while Control manages automated calibration and reliable operation of quantum hardware. Together, these products unify the quantum computing stack for scalable performance across various qubit modalities.
Copper is a community platform that utilizes interactive features to facilitate book discussions and event hosting, enhancing engagement between authors and readers. It addresses the limited networking opportunities in the literary space by fostering meaningful connections around shared reading experiences.
Funding: $3.1M
Rough estimate of the amount of funding raised
Funding: $3.1M
Rough estimate of the amount of funding raised
Deep Planet utilizes satellite imagery and AI-driven analytics to optimize soil organic carbon management and nutrient application for vineyards and agricultural producers. This technology enhances grape yield and resilience against climate change, addressing the challenges of declining agricultural productivity and environmental sustainability.
Funding: $2.7M
Rough estimate of the amount of funding raised
Funding: $2.7M
Rough estimate of the amount of funding raised
ExcepGen develops a platform that modifies cellular responses to DNA and mRNA, enhancing the efficacy of nucleic acid therapeutics. This approach mitigates undesirable cellular pathways, improving the delivery and effectiveness of gene therapies and vaccines for rare diseases.
Funding: $4.2M
Rough estimate of the amount of funding raised
Funding: $4.2M
Rough estimate of the amount of funding raised
Forte offers an integrated, data‑driven platform for outcomes‑based workforce development, combining the ForteCompass SaaS tool for program design, enrollment, tracking, and analytics with Forte360 managed services that handle curriculum selection, provider oversight, and accountability. Its ForteFund financing model funds training at zero out‑of‑pocket cost for learners or sponsors, using outcome‑based repayment to scale impact. The solution enables corporations, governments, and nonprofits to launch, manage, and finance large‑scale retraining and upskilling initiatives efficiently and with measurable results.
Funding: $5.6M
Rough estimate of the amount of funding raised
+ 2 Other investorsRegal Funds Management
+ 2 Other investorsRegal Funds Management
Funding: $5.6M
Rough estimate of the amount of funding raised
Granza Bio develops a precision shell platform that utilizes autonomous "attack particles" from cytotoxic immune cells to deliver therapeutic cargo directly to cancer cells and hard-to-reach tissues. This technology minimizes toxicity and adverse side effects, enhancing the effectiveness of treatments for cancer and autoimmune diseases.
Kadeya provides a closed-loop beverage system featuring autonomous vending stations for workplaces. This system dispenses drinks on demand into reusable bottles which are then cleaned and refilled at any kiosk. The service eliminates single-use plastic waste while promoting employee hydration and corporate sustainability goals.
Louisa AI provides an AI‑powered relationship intelligence platform that aggregates internal knowledge, external news, and proprietary data to surface warm cross‑sell and origination opportunities before competitors act. By building a dynamic relationship graph and expertise map, the system delivers real‑time deal prompts to the right individuals across divisions, helping investment banks, capital managers, consulting firms, and law firms increase revenue efficiency.
Funding: $5.0M
Rough estimate of the amount of funding raised
+ 3 Other investorsNucleus VenturesPalm Drive Capital
+ 3 Other investorsNucleus VenturesPalm Drive Capital
Funding: $5.0M
Rough estimate of the amount of funding raised
Mote is a Chrome extension and mobile app that enables educators and learners to create and embed voice recordings within commonly used applications, enhancing accessibility and engagement in the learning process. By facilitating personalized audio feedback in over 50 languages, Mote addresses the challenge of providing individualized instruction efficiently, ultimately improving learning outcomes for diverse student populations.
Funding: $1.7M
Rough estimate of the amount of funding raised
Funding: $1.7M
Rough estimate of the amount of funding raised
Motives offers an AI-powered platform for rapid qualitative consumer research, conducting automated video interviews to deliver actionable insights within 48 hours. This accelerates concept testing, creative refinement, and understanding of consumer motivations for marketing and product teams.
5+
200+Approximate amount of employees
OpenSponsorship is an online platform that connects brands with over 20,000 professional and collegiate athletes, music artists, and content creators for sponsorship opportunities. By providing a transparent campaign management system and data-driven insights, it enables brands to efficiently find and collaborate with the right influencers to maximize their marketing impact.
Founded 2014
Parsewise provides an AI‑driven decision platform that extracts and structures data from unstructured documents for risk assessment. It automates underwriting, claims, and portfolio diligence workflows, delivering traceable insights that reduce manual effort. The solution helps insurers, asset managers, and regulators improve margins, accelerate diligence, and strengthen regulatory compliance.
PingThings offers the PredictiveGrid™, a high-performance platform for managing and analyzing time series data from various sensors in the utility industry. By enabling real-time and historical data access with extreme read and write capabilities, it allows organizations to optimize their sensor data management and enhance operational efficiency.
Plexe AI enables users to generate custom, production-ready machine learning models directly from natural language prompts. The platform connects to raw data sources to automatically engineer, train, and deploy tailored AI solutions like fraud detection or recommendation engines. It provides full transparency into model performance metrics and training details, accelerating the transition from data insight to actionable ML deployment.
Probably Genetic provides free, clinical-grade genetic testing to help families find answers for unexplained symptoms related to rare diseases. The company utilizes AI and genetics expertise to facilitate at-home sample collection, CLIA-certified lab analysis, and subsequent genetic counseling. This service aims to end the diagnostic odyssey by identifying genetic variants that guide targeted treatments and healthcare decisions.
Funding: $10.7M
Rough estimate of the amount of funding raised
Funding: $10.7M
Rough estimate of the amount of funding raised
Proof of Impact provides a data intelligence platform that aggregates and analyzes ESG and impact data, enabling businesses to efficiently manage their sustainability reporting. By offering benchmarking insights and data-driven recommendations, the platform helps organizations identify operational efficiencies and enhance their competitive positioning in the market.
Funding: $9.2M
Rough estimate of the amount of funding raised
Funding: $9.2M
Rough estimate of the amount of funding raised
The startup develops a cardiovascular therapeutics platform focused on creating novel treatments for acute and chronic cardiovascular diseases, specifically targeting calcific aortic valve stenosis. By utilizing market access strategies, the company aims to enhance patient quality of life and delay the need for surgical valve replacement through non-invasive treatment options.
Funding: $3.0M
Rough estimate of the amount of funding raised
Funding: $3.0M
Rough estimate of the amount of funding raised
Uncanny provides an AI-driven production toolkit for live streamers and content creators, enabling real-time enhancements such as automated scene switching and audience engagement analytics. This technology addresses the challenges of professional-quality broadcasting by simplifying complex production tasks, allowing creators to focus on content rather than technical execution.
Showing 7 of 7 unmatched portfolio companies